Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CELC compared with MDGL: revenue, margins and what each company keeps, and the suppliers and customers both name
CELC
Celcuity Inc.
Change
Mkt cap
Revenue
Revenue
MDGL
Madrigal Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CELC
Celcuity Inc.
vs
MDGL
Madrigal Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
CELC: latest quarter not drawable. MDGL: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CELC, solid
MDGL, dashed
CELC
Celcuity Inc.
Change
69.27
▼
−0.05%
· post 69.27
Mkt cap
$3.4B
Revenue
—
Revenue
—
MDGL
Madrigal Pharmaceuticals, Inc.
Change
430.17
▼
−0.35%
· post 433.06
Closed
Oct 30 '26
Mkt cap
$9.9B
Revenue
$364M
Q2 FY26
Revenue
$958M
FY25
vs
Compare
Closed
Oct 30 '26
CELC
Celcuity Inc.
vs
MDGL
Madrigal Pharmaceuticals, Inc.
69.27
▼
−0.05%
post 69.27
Price
430.17
▼
−0.35%
post 433.06
$3.4B
Mkt cap
$9.9B
—
Revenue
$364M
Q2 FY26
—
Revenue
$958M
FY25
Change
Change
CELC
69.27
▼
−0.05%
vs
MDGL
430.17
▼
−0.35%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CELC
0
None
Shared
0
No disclosed counterparties: CELC.
Only MDGL
8
PFE
Pfizer
supplier
—
Gregory Pharmaceutical Holdings, Inc. (d/b/a UPM Pharmaceuticals)
unlisted
supplier
—
Roche
unlisted
supplier
—
Cowen
unlisted
supplier
4 more · MDGL chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR